IL17A and neoplasm: Bifidobacterium can directly induce DC maturation and cytokine (IFNγ, TNFα, IL-10, IL-17) production, thus promoting anti-tumor immunity and anti-PD-L1 efficacy and almost inhibiting tumor progression after combination therapy with PD-L1 monoclonal antibody (mAb) (104).